Posterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

Recruiting

Irreversible ElectroporationPosterior Wall Substrate Modification Using Irreversible Electroporation for Paroxysmal Atrial Fibrillation

Sponsor:

Brigham and Women's Hospital

Code:

NCT06364215

Conditions

Atrial Fibrillation Paroxysmal

Eligibility Criteria

Sex: All

Age: 21 - 70+

Healthy Volunteers: Not accepted

Interventions

Farapulse PFA, Pulmonary Vein Isolation alone

Farapulse PFA, Pulmonary Vein Isolation and Left atrial Posterior Wall Isolation

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2025-09-14. This information was provided to ClinicalTrials.gov by Brigham and Women's Hospital on 2025-08-22.